Ann: Trading Halt, page-61

The key point in the announcement is this

<Neuren> advises that the reason for the request is to facilitate an orderly market in the
Company’s securities pending an announcement in relation to the top line results of
its Phase 2 clinical trial in Phelan-McDermid syndrome;

Especially the "to facilitate an orderly market"

Given that everything done by management so far as been done in the most prudent and professional manner, on top of the rise from $10.02 to $17.14 over the past few weeks - I take a read on the above as positve and that the results will indeed be positive.

Also - it is the way the phase X announcements run by Neuren have always been performed by Neuren management in the past - Trading Halt and then announce.

We will know by 10am on Monday morning - my guess is some time after 4pm tomorrow.

Till then - get back to your real jobs!

GLTAH.